Pre-launch · We're opening Reserve Meds to a limited first cohort. Join the waitlist ›

Hemophilia A in Turkey

How patients in Turkey access treatment for hemophilia a via Named Patient Program.

About Hemophilia A

Hematology

Treatment access in Turkey

Turkey's TITCK operates a named-patient program; HCPs coordinate with Turkish Pharmacists' Association.

For patients in Turkey with hemophilia a whose required therapy is not locally registered, a Named Patient Program pathway typically applies.

How Reserve Meds supports patients with hemophilia a in Turkey

  1. Patient or physician contacts us with disease details and therapy requested.
  2. We verify eligibility in Turkey and confirm US supply.
  3. Treating physician in Turkey issues prescription and justification.
  4. We file Turkey-specific NPP/personal-import paperwork.
  5. We source the drug from a DSCSA-compliant US specialty wholesaler.
  6. Cold-chain shipment to the patient's physician or hospital pharmacy in Turkey.

Patient support throughout

  • Case manager from request through delivery.
  • Documentation translation where needed.
  • Physician-to-physician support for clinical justification.
  • Re-supply coordination for chronic therapy.

Start a request

Start a Hemophilia A request in Turkey

Review & oversight. Content on this page is reviewed by Reserve Meds's clinical and regulatory team. A US-licensed pharmacist reviews every prescription before dispensing. Regulatory posture is informational, not legal advice; case-specific questions route to retained outside counsel. Review methodology ›
Last medically reviewed: .